APA (7th ed.) Citation

M, T., H, Y., T, O., K, I., M, K., H, M., . . . N, M. (2025). Overall survival and subsequent therapy patterns in Japanese patients with ER+/HER2- advanced breast cancer treated with palbociclib plus letrozole in the first-line setting: A final analysis. Breast cancer (Tokyo, Japan), 32(6), 1482. https://doi.org/10.1007/s12282-025-01760-0

Chicago Style (17th ed.) Citation

M, Takahashi, et al. "Overall Survival and Subsequent Therapy Patterns in Japanese Patients with ER+/HER2- advanced Breast Cancer Treated with Palbociclib Plus Letrozole in the First-line Setting: A Final Analysis." Breast Cancer (Tokyo, Japan) 32, no. 6 (2025): 1482. https://doi.org/10.1007/s12282-025-01760-0.

MLA (9th ed.) Citation

M, Takahashi, et al. "Overall Survival and Subsequent Therapy Patterns in Japanese Patients with ER+/HER2- advanced Breast Cancer Treated with Palbociclib Plus Letrozole in the First-line Setting: A Final Analysis." Breast Cancer (Tokyo, Japan), vol. 32, no. 6, 2025, p. 1482, https://doi.org/10.1007/s12282-025-01760-0.